Research Scientist, Pathobiology – Multiplexing and Emerging Technologies

The Pathobiology group is seeking a highly motivated individual with experience in multiplex immunofluorescence -based technologies to join the Multiplexing and Emerging Technology group. The successful candidate will work closely with internal research groups as well as external collaborators to identify and validate novel drug targets and their mechanism of action in areas of oncology, fibrosis, virology, and inflammation. 

The successful candidate will have a background in biology or a related discipline and have experience in developing IHC, immunofluorescence and multiplex assays. Knowledge of, and experience with tissue based emerging technologies and analysis tools is desirable. 

The successful candidate must be self-motivated and detail-oriented, exhibit strong organizational and communication skills with the ability to manage multiple priorities, and a proficient team-player.

Essential Duties and Job Functions: 

Work closely with investigators across Gilead to understand project requirements and execute tissue-based assays

Develop and execute experimental protocols to answer biological questions using multiplexing technologies (e.g. Ultivue, Akoya) and imaging platforms (Zeiss AxioscanZ1, Akoya Polaris or similar).

Lead evaluation of emerging tissue-based technologies through a combination of in-house efforts and the use of relevant CROs.

Lead outsourced studies with CROs/ vendors, as applicable.

Knowledge, experience, and skills: 

PhD with 0-2 years of relevant work experience, or a master’s degree with 6+ years of relevant experience.

The successful candidate will have experience in multiplex IF assay development and show curiosity-driven engagement in scientific problems.

Experience with multiple automated IHC platforms and imaging platforms is required.

Strong verbal and written communication, teamwork and interpersonal skills are required.

Experience with emerging tissue-based technologies is a plus.

Experience in image analysis software (i.e.: Visiopharm, Halo, or similar) and data analysis programs (Excel, Spotfire, Prism, etc.) is preferred but not required.